Non-aneurysmal subarachnoid hemorrhage in 173 patients: a prospective study of long-term outcome
|
|
- Milo Carroll
- 6 years ago
- Views:
Transcription
1 ORIGINAL ARTICLE Non-aneurysmal subarachnoid hemorrhage in 173 patients: a prospective study of long-term outcome J. Konczalla, J. Schmitz, S. Kashefiolasl, C. Senft, V. Seifert and J. Platz Department of Neurosurgery, Goethe-University Hospital, Frankfurt am Main, Germany Keywords: aneurysm, long-term outcome, nonaneurysmal, nonperimesencephalic, perimesencephalic, prepontine, SAH, SF-36, short-term, subarachnoid hemorrhage Received 19 January 2015 Accepted 27 April 2015 European Journal of Neurology 2015, 0: 1 8 doi: /ene Background and purpose: In some patients with subarachnoid hemorrhage (SAH) a bleeding source cannot be identified. Perimesencephalic (PM) SAH is assumed to have an excellent outcome. Our objective was to analyze the longterm physical and psychological outcome of patients after non-aneurysmal SAH. Methods: One hundred and seventy-three patients met the inclusion criteria. Short-term follow-up 6 months after SAH was assessed according to the modified Rankin Scale (0 2 favorable). A short-form health survey with 36 questions (SF-36) and eight scales was used as questionnaire for long-term followup. Results: Thirty-seven answers were received from the two groups, PM and non-perimesencephalic (NPM) SAH, on average 76 months after ictus (range years). PM- and NPM-SAH without Fisher grade 3 blood pattern have excellent short-term outcomes. The quality of life (QoL) is significantly reduced after non-aneurysmal SAH, especially in NPM-SAH. In particular, patients with a Fisher 3 blood pattern had significantly higher risks for cerebral vasospasm, delayed cerebral ischaemia, unfavorable outcome, reduced QoL and mortality in short- and long-term follow-up. Conclusions: Excluding rolph, only patients with a PM-SAH have a similar QoL at long-term follow-up compared to the standard population. Patients with NPM-SAH have a significantly decreased QoL in long-term follow-up. Furthermore, the Fisher 3 blood pattern group in particular had a significantly worse outcome at short-term and long-term follow-up. Therefore the NPM- SAH group was stratified into patients with Fisher 3 blood pattern and patients without Fisher 3 in further investigations. Background Spontaneous subarachnoid hemorrhage (SAH) is usually caused by rupture of an intracranial aneurysm, but in up to 15% of patients with spontaneous SAH no discernible bleeding source can be identified despite repeated radiological imaging [1,2]. The majority of patients with non-aneurysmal SAH (NASAH) are in good clinical condition at admission [3 9]. The blood Correspondence: J. Konczalla, Department of Neurosurgery, Johann Wolfgang Goethe-University Frankfurt am Main, Schleusenweg 2-16, Frankfurt am Main, Germany (tel.: ; fax: ; J.Konczalla@med.uni-frankfurt.de). Clinical Trial Registration: URL: Unique identifier: NCT distribution can be described as perimesencephalic/ prepontine or non-perimesencephalic (NPM) [4,6,9]. Depending on the pattern of SAH the clinical course of the patients can be similar to aneurysmal SAH [6,9]. NASAH and especially perimesencephalic (PM) SAH are therefore often associated with favorable short-term outcome compared to aneurysmal SAH [1,2,6,10,11]. However, data on patients with spontaneous NASAH are commonly based on case series and are therefore rare [3,4,12 15]. But even more, data assessing the long-term outcome are scarce [5,16] and lacking for physiological and psychological outcome in a series with more than 50 patients. Therefore, the aim of the present study was to investigate the long-term physical and psychological outcome in 1
2 2 J. KONCZALLA ET AL. Figure 1 Flow diagram with detailed information about enrollment and short- and long-term follow-up. From over 1400 patients 173 patients were eligible to receive the questionnaire. Short- and long-term follow-up results and mortality rates are presented. Overall in every group a good response rate was achieved of over 50%, especially against the background of patients suffering from NASAH starting 15 years ago. patients suffering from non-aneurysmal spontaneous SAH prospectively. Material and methods Between 1999 and 2012 information on all patients with SAH, including patient characteristics, treatment, radiological features and outcome, was prospectively entered into a computerized database. SAH was confirmed on computed tomography (CT) or lumbar puncture. Only patients with a non-traumatic SAH were included. All patients had a regular follow-up after 6 months following our hospital algorithm. Patients with an SAH more than 18 months ago received additionally a questionnaire; see also the flow chart (Fig. 1). In all, 173 patients (12% of all SAH patients) with a spontaneous NASAH after diagnostic work-up were identified. In our hospital algorithm all patients with SAH underwent angiography including three-dimensional digital subtraction angiography (DSA) since 2002 to rule out intracranial sources for SAH. In the case of a negative initial angiography, DSA was repeated after 14 days. Additionally, magnetic resonance imaging (MRI) of head/spine was performed to rule out any spinal bleeding sources. In patients with blood distribution exceeding the typical perimesencephalic pattern, a third DSA was performed 3 months after SAH. Our treatment protocol includes the application of nimodipine in all patients with SAH from the day of admission and has been described in detail previously [17]. NASAH was stratified into PM- and NPM-SAH. Recently published data showed differences between Fisher grade 3 blood pattern and NPM-SAH without Fisher 3 blood pattern [9]; therefore the NPM-SAH group was further stratified into Fisher 3 blood pattern and NPM-SAH without Fisher 3 blood pattern. NASAH was defined as perimesencephalic hemorrhage according to Van Gijn et al. [1] and Rinkel et al. [10] hemorrhages located around
3 LONG-TERM OUTCOME AFTER NON-ANEURYSMAL SAH 3 (a) (b) (c) Figure 2 Long-term outcome compared to standard population, measured by SF-36. The eight items of the SF-36 are shown on the x-axis. On the left side the ordinate is scaled metrically. The line graph shows the standard population, whereas the bar chart represents the different groups. *P < (a) Long-term outcome of NASAH patients. Pfi/rolph/ghp/rolem and mhi were significantly reduced after SAH compared to the standard population. (b) The two bars represent the long-term outcome of the two subgroups (white for PM-SAH, grey for NPM-SAH). In the PM-SAH group only rolph is significantly reduced compared to the standard population, whereas in the NPM-SAH group all physical items (pfi/rolph/pain/ghp) are significantly reduced. (c) The NPM subgroups Fisher 3 blood pattern (light grey) and NPM without Fisher 3 blood pattern (dark grey) were compared to the standard population. In this subgroup analysis in both groups all items are reduced compared to the standard population, but for the NPM without Fisher 3 blood pattern no significant decrease was calculated. In the Fisher 3 blood pattern group one physical item (rolph) and all psychological items (vital/social/rolem/mhi) are significantly reduced. the brain stem, most often located in the interpeduncular cistern. For NPM-SAH blood was not located mainly in the interpeduncular cistern but in the Sylvian cistern, interhemispheric cistern, convexity or a CT-negative and lumbar puncture positive bleeding (Fig. S1). The first (short-term) follow-up was performed 6 months after ictus. Outcome was measured according to the modified Rankin Scale (mrs) and stratified into favorable (mrs 0 2) and unfavorable (mrs 3 6) after 6 months. Trial registration This prospective non-interventional study was approved by the local ethics committee of Goethe-University Hospital Frankfurt and registered on (identifier no. NCT ). Assessment and statistical analysis From November 2013 to February 2014 patients at least 18 months after ictus of NASAH received a regular mail. This mail included a letter explaining the study purpose, statement of consent and the postal questionnaire consisting of a short-form health survey with 36 simple questions (SF-36) [18,19], which was used for the long-term (second) follow-up. These 36 questions were converted to an eight-item scale, which was divided into two categories (physical and psychological health) (Table 1). Furthermore the data can be compared with a standard population from the US health survey (n = 2474) to make our results comparable with future data. Table 1 The items of SF-36 are listed with their appropriate abbreviations Items Physical Physical functioning pfi Role limitations because of physical rolph health problems Bodily pain pain General health perceptions ghp Psychological Vitality vital Social functioning social Role limitations because of rolem emotional problems General mental health mhi If answers were not received after 3 months telephone interviews were carried out with the patients, their family members or their general practitioner. An unpaired t test with Welch correction was used for parametric statistics. For categorical variables Fisher s exact test was used. Results with a P value <0.05 were considered statistically significant. All calculations were made with standard commercial software (IBM SPSS Inc., Armonk, NY, USA). Patient characteristics Results Abbreviation A cohort of 173 patients met the inclusion criteria (at least 18 months after non-aneurysmal non-traumatic SAH), including patients with ictus from 1999 to patients (9%) had died by the short-term outcome (Table 2). Another 16 patients died by the long-term outcome questionnaire (9%) (Table 3); most of them
4 4 J. KONCZALLA ET AL. Table 2 Patients characteristics, complications and short-term follow-up after 6 months P (NPM Fisher 3 vs. NPM w/o Fisher 3) Odds ratio (95% CI) NPM w/o Fisher 3 NPM Fisher 3 Odds ratio (95% CI) P (PM- vs. NPM-SAH)* NPM-SAH PM-SAH Characteristics NASAH No. of patients Mean age SD NS NS WFNS I III at 151 (87) 79 (91) 72 (84) NS 19 (59) 53 (98) < ( ) for w/o Fisher 3 admission Early hydrocephalus 46 (27) 20 (23 26 (30) NS 19 (59 7 (13 < ( ) for Fisher 3 Shunt dependence 15 (9) 5 (6) 10 (12) NS 4 (13) 6 (11) NS Cerebral vasospasm 37 (17) 13 (15) 24 (28) < ( ) 19 (59) 5 (9) < ( ) for Fisher 3 28 (13) 8 (9) 20 (23) < ( ) 14 (44) 6 (11) < ( ) for Fisher 3 Delayed cerebral ischaemia Favorable outcome 147 (85) 76 (87) 71 (83) NS 20 (63) 51 (88) < ( ) for w/o Fisher 3 Death 16 (9) 7 (8) 9 (10) NS 8 (25) 1 (2) < ( ) for Fisher 3 NASAH, non-aneurysmal subarachnoid hemorrhage; PM, perimesencephalic; NPM, non-perimesencephalic; 95% CI, 95% confidence interval; NS, not significant (P > 0.05); NPM Fisher 3, NPM- SAH with Fisher 3 blood pattern; NPM w/o Fisher 3, NPM-SAH without Fisher 3 blood pattern; WFNS, World Federation of Neurological Societies; favorable outcome, modified Rankin Scale (mrs) 0 2. *Unpaired t test for parametric statistics and Fisher exact test for categorical variables. (75%) were 70 years or older. In the majority (56%) the definitive cause of death is known (Table 4). In seven patients with a mean age of 74.4 years a definitive diagnosis was not available. In a 65-year-old male and an 86-year-old female intracranial bleeding was assumed. Unfortunately, scans were not available, and therefore it was not possible to differentiate between potential causes (like SAH, intracranial hemorrhage for example). Overall, one rebleeding occurred without detection of a bleeding source also after the second round of diagnostic work-up. Of the remaining 141 patients five patients (4%) did not answer (Table 3). Finally, answers were received from 74 patients (52%). 62 patients (44%) were lost to follow-up, resulting in an acceptable to good response rate of 56% for a questionnaire up to 15 years after ictus [20]. Answers were received on average more than 6 years after ictus (76.1 months, range months). The mean age at ictus was years. Thirty-seven answers were received from the two groups, PM- and NPM-SAH. The mean age and time interval from ictus did not differ significantly between them (Table 2). Concomitant diseases and complications Whereas the admission status between the PM- and NPM-SAH groups was similar, patients with a Fisher 3 blood pattern had a significantly worse admission status compared to patients with NPM-SAH without Fisher 3 [59% vs. 98%; P < ; odds ratio (OR) 36.3]. Similarly the rate of early hydrocephalus did not differ between the PM- and NPM-SAH groups but was significantly increased in the Fisher 3 blood pattern. However, the rate of shunt dependence was similar in all groups (Table 2). Cerebral vasospasm and delayed cerebral ischaemia In this cohort the NPM-SAH group compared to the PM-SAH group had cerebral vasospasm (CVS) (28% vs. 15%; P < 0.05) and delayed cerebral ischaemia (DCI) (23% vs. 9%; P < 0.05) significantly more often. However, for Fisher 3 blood pattern the data demonstrate more clearly a higher rate of CVS (59% vs. 9%; P < 0.01) and DCI (44% vs. 11%; P < 0.01) compared to NPM-SAH without Fisher 3 blood pattern. Therefore, the outcome of the Fisher 3 group was significantly reduced (Table 2) and a further stratification into these two subgroups seems reasonable for long-term follow-up. Neurological complications after NASAH At long-term follow-up nine patients (12%) had a newly diagnosed neurological or psychiatric disease
5 LONG-TERM OUTCOME AFTER NON-ANEURYSMAL SAH 5 Table 3 Mortality and response rate Characteristics Number of patients at ictus Deaths at short-term + long-term follow-up P value* Number of patients sent questionnaire Response rate No answer NASAH = 32 (18) (56) 5 (4) PM-SAH 87 (50) = 12 (14) NS vs. NPM-SAH (51) 1 (1) NPM-SAH 86 (50) = 20 (23) (62) 4 (6) NPM-SAH with 32 (18) = 13 (41) <0.01; OR (53) 1 (5) Fisher 3 pattern NPM-SAH without Fisher 3 54 (31) = 7 (13) 95% CI for Fisher 3 vs. w/o Fisher (66) 3 (6) NASAH, non-aneurysmal subarachnoid hemorrhage; PM, perimesencephalic; NPM, non-pm; OR, odds ratio; 95% CI, confidence interval; NS, not significant (P > 0.05). *Fisher exact test for categorical variables. Table 4 Outcome of NASAH, stratified to PM-, NPM-SAH, Fisher 3 blood pattern and without Fisher 3 blood pattern Characteristics NASAH PM-SAH NPM-SAH P value* (PM vs. NPM) NPM-SAH with Fisher 3 NPM-SAH without Fisher 3 P value* (with Fisher 3 vs. without Fisher 3) No. of. patients Rebleeding 1 (1) 0 1 (3) NS 1 (11) 0 NS Newly diagnosed after NASAH Psychiatric disease 5 (7) 2 (5) 3 (8) NS 2 (22) 1 (4) NS Seizure 5 (7) 1 (3) 4 (11) NS 2 (22) 2 (7) NS Chronic headache 3 (4) 0 3 (8) NS 2 (22) 1 (4) NS No. of patients with 9 (12) 3 (8) 6 (16) NS 4 (44) 2 (7) NS new diagnosis Death between short-term 16 of 157 (10) 5 of 80 (6) 11 of 77 (14) NS 5 of 24 (21) 6 of 53 (11) NS and long-term follow-up Deaths due to Intracranial bleeding 2 of 16 (13) 0 of 5 2 of 11 (18) NS 0 of 5 2 of 6 (17) NS malignant tumors 3 (19) 1 (20) 2 (18) NS 1 (20) 1 (17) NS Other causes 4 (25) 2 (40) 2 (18) NS 0 2 (33) NS Without definitive diagnosis 7 (44) 2 (40) 5 (45) NS 4 (80) 1 (17) NS NASAH, non-aneurysmal subarachnoid hemorrhage; PM, perimesencephalic; NPM, non-perimesencephalic; NS, not significant (P > 0.05). *Unpaired t test for parametric statistics and Fisher exact test for categorical variables. after NASAH: three had chronic headache, five had psychiatric diseases (including four with additional depression) and five had seizures (Table 4). The subgroup of PM-SAH seems to be less often affected, even though this was not statistically significant. Of these nine patients, only three had a PM-SAH, whereas six had a NPM-SAH. Once again, the Fisher 3 group (44%) had complications significantly more often compared to the NPM-SAH group without Fisher 3 blood pattern (7%; Table 4). Long-term outcome of NASAH and comparison with standard population Three of the four physical items (Table 1) were reduced compared to the general population: pfi (P < 0.01), rolph (P < 0.001) and ghp (P < 0.01). For the psychological items two of four were reduced: rolem (P < 0.05) and mhi (P < 0.05). The items pain, vital and social were also reduced, but this was not statistically significant (Fig. 2a). A comparison to the general population was performed, using the US health survey. This made our results comparable with future data. Results of the SF-36 are shown in Fig. 2a. Compared to the general population, patients after NASAH experienced a reduction in all eight classes of the SF-36 (Fig. 2a). Therefore, patients after NASAH had physical and psychological disturbances. Long-term outcome and comparison of PM- and NPM- SAH Whereas PM-SAH is generally considered a benign entity, patients after NPM-SAH, especially with a
6 6 J. KONCZALLA ET AL. Fisher 3 bleeding pattern, are known to have a worse outcome after 6 months. This was demonstrated especially in recent years due to more complex cases (e.g. anticoagulation) [6,7,9,21]. Also in our cohort a high mortality rate was identified for this group: 25% up to short-term follow-up and 41% up to long-term follow-up (Tables 2 and 3). The patient characteristics at short-term outcome (Table 2) and long-term outcome (Table 4) of the PM- and NPM-SAH groups are very similar. But at long-term follow-up in all items except the rolem the NPM-SAH group has reduced values compared to PM-SAH. For PM-SAH only the physical item rolph was decreased significantly, whereas for the NPM- SAH group all physical items (pfi, rolph, pain and ghp) were reduced significantly compared to the standard population. Therefore, the NPM-SAH group seems to have a worse long-term outcome and higher mortality rates (Table 2 and Fig. 3b). Long-term outcome and comparison of NPM-SAH with Fisher 3 pattern versus NPM-SAH without Fisher 3 pattern A closer look at the NPM-SAH revealed that it is necessary to stratify this group into Fisher 3 blood pattern and NPM-SAH without the subgroup Fisher 3. Patients with a Fisher 3 blood pattern had a significantly worse World Federation of Neurological Societies status and higher hydrocephalus rate on admission. Also the rate of CVS, DCI, unfavorable outcome and death was significantly higher (Table 2). The highest rate of deaths at short-term outcome was in the Fisher 3 group too (Table 4). Unfortunately only nine patients with a Fisher 3 blood pattern answered the questionnaire (with an acceptable to good response rate of 53% [20]), so that statistical analysis is limited. Also 44% had neurological or psychiatric diseases after NASAH (Table 4), which may influence the data. Nonetheless, except for pfi (P ~ 0.5), pain (P = 0.07) and ghp (P = 0.05), all other items were significantly lower compared to the standard population, whereas for the NPM-SAH without Fisher 3 group no significant differences were calculated (Fig. 3c). Discussion In up to 15% of patients suffering from SAH, no source of bleeding can be found [3 5,7,8,14]. The majority of patients with NASAH are in good clinical condition at admission [3 9]. Non-aneurysmal and especially PM-SAH are therefore often associated with favorable short-term outcome compared to aneurysmal SAH [1,2,6,10,11]. However, data on patients with spontaneous NASAH are commonly based on case series and are therefore rare [3,4,6,8,9,12 15]. But even more, data assessing the long-term outcome are scarce [5,16] and lacking for physiological and psychological outcome in a series with more than 50 patients. Our neurovascular database was therefore analyzed concerning patients suffering from NASAH. In our study, 85% achieved a favorable outcome at short-term follow-up (Table 2). As for aneurysmal SAH [22] patients after NASAH had a reduced quality of life (QoL) in all eight classes of the SF-36 compared to the reference population (Fig. 2). Therefore, after NASAH, apart from the patients with newly diagnosed neurological or psychiatric diseases (18%), most patients had physical and psychological disturbances at long-term follow-up. Three of four physical items were statistically significantly reduced compared to the general population: pfi, rolph and ghp. For the psychological items two of four items were reduced significantly: rolem and mhi (Fig. 2a). This was even more significant in the group of NPM- SAH, which had significant reductions in all physical items (Fig. 2b). As in the study by Beseoglu et al. [5] the QoL is reduced in the NPM-SAH group compared to PM-SAH. Kapapa et al. [23] and Tjahjadi et al. [24] presented already a reduced QoL after SAH, but data for PM-SAH are still lacking. Except for pain and social all scales are decreased in PM-SAH but only significantly for rolph (Fig. 2b), suggesting a similar QoL after PM-SAH excluding the rolph. The highest risk for unfavorable outcome and/or death was found for the Fisher 3 blood pattern group (Table 2). Therefore the NPM-SAH data were stratified into subgroups with Fisher 3 blood pattern and without Fisher 3. The NPM-SAH without Fisher 3 group had a very similar excellent outcome like PM-SAH (Table 2). The Fisher 3 group had a very high risk for unfavorable outcome (OR 10.2) and mortality after 6 months (25%; OR 17.7, Table 2) and at long-term follow-up (41%; OR 4.6, Table 3). For the Fisher 3 group the QoL is reduced in all eight scales, but significantly in any psychological scales (vital, social, rolem, mhi) and also in rolph (Fig. 2c). 44% had neurological or psychiatric diseases after NASAH (Table 4), which may influence the outcome of these nine patients. Some reports also identified different functional outcomes of NASAH according to the blood distribution [7,9,21]. The reason for the worse short- and long-term outcomes seems to be the higher incidence of CVS, DCI and death (Table 2) [6,7,9,13,21,25] and the higher incidence of newly
7 LONG-TERM OUTCOME AFTER NON-ANEURYSMAL SAH 7 diagnosed neurological and psychiatric diseases (Table 4). Limitations The study has several limitations. Statistical analysis was retrospectively performed for the short-term outcome and conducted from a single center. Due to the retrospective design there are the typical restrictions such as the lack of data not documented initially in the medical records. The long-term follow-up was performed prospectively, but based on the data of our computerized database. Also 62 patients (44%) were lost to follow-up, limiting the data, but resulting in an acceptable to good response rate of 56% for a questionnaire up to 15 years after ictus. Patients with Fisher 3 blood pattern had a significantly higher rate of neurological and psychiatric diseases, which may influence the outcome. But the number of absolute patients for Fisher 3 blood pattern was only nine. Conclusion Excluding rolph, only patients with a PM-SAH have a similar QoL at long-term follow-up compared to the reference population. Patients with NPM-SAH had a significantly decreased QoL at the long-term followup. In this large study a significantly worse clinical outcome was identified for the Fisher 3 blood pattern group at short-term and long-term follow-up. Therefore our advice is to stratify the NPM-SAH into patients with Fisher 3 blood pattern and without Fisher 3 in further investigations. Disclosure of conflicts of interest The authors declare no financial or other conflicts of interest. Funding statement The author JK receive foundation grants for earmarked funding of research projects of the medicalmdepartment of Goethe-University. Acknowledgements We thank Marina Heibel and Anne Sicking for excellent technical support. This study was partly funded by Frankfurt University Hospital s Foundation grants. Author contributions: JK, DS, SK, JP acquired and analyzed the data. JK performed the statistical analysis and drafted the manuscript. JK, CS, VS interpreted the data and contributed to critical revision of the manuscript for important intellectual content. JP performed critical supervision of the manuscript. All authors read and approved the final manuscript. Supporting Information Additional Supporting Information may be found in the online version of this article: Figure S1. Perimesencephalic and non-perimesencephalic SAH. References 1. Van Gijn J, van Dongen KJ, Vermeulen M, Hijdra A. Perimesencephalic hemorrhage: a nonaneurysmal and benign form of subarachnoid hemorrhage. Neurology 1985; 35: Van Gijn J, Rinkel GJ. Subarachnoid haemorrhage: diagnosis, causes and management. Brain 2001; 124: Gupta SK, Gupta R, Khosla VK, et al. Nonaneurysmal nonperimesencephalic subarachnoid hemorrhage: is it a benign entity? Surg Neurol 2009; 71: ; discussion Ildan F, Tuna M, Erman T, G ocer AI, Cetinalp E. Prognosis and prognostic factors in nonaneurysmal perimesencephalic hemorrhage: a follow-up study in 29 patients. Surg Neurol 2002; 57: ; discussion Beseoglu K, Pannes S, Steiger HJ, H anggi D. Long-term outcome and quality of life after nonaneurysmal subarachnoid hemorrhage. Acta Neurochir (Wien) 2010; 152: Konczalla J, Platz J, Schuss P, Vatter H, Seifert V, G uresir E. Non-aneurysmal non-traumatic subarachnoid hemorrhage: patient characteristics, clinical outcome and prognostic factors based on a single-center experience in 125 patients. BMC Neurol 2014; 14: Nayak S, Kunz AB, Kieslinger K, Ladurner G, Killer M. Classification of non-aneurysmal subarachnoid haemorrhage: CT correlation to the clinical outcome. Clin Radiol 2010; 65: Pyysalo LM, Niskakangas TT, Keski-Nisula LH, K ah ar a VJ, Ohman JE. Long term outcome after subarachnoid haemorrhage of unknown aetiology. J Neurol Neurosurg Psychiatry 2011; 82: Konczalla J, Schuss P, Platz J, Vatter H, Seifert V, G uresir E. Clinical outcome and prognostic factors of patients with angiogram-negative and non-perimesencephalic subarachnoid hemorrhage: benign prognosis like perimesencephalic SAH or same risk as aneurysmal SAH? Neurosurg Rev 2015; 38: Rinkel GJ, Wijdicks EF, Hasan D, et al. Outcome in patients with subarachnoid haemorrhage and negative angiography according to pattern of haemorrhage on computed tomography. Lancet 1991; 338: Rinkel GJ, Wijdicks EF, Vermeulen M, Hasan D, Brouwers PJ, van Gijn J. The clinical course of perime-
8 8 J. KONCZALLA ET AL. sencephalic nonaneurysmal subarachnoid hemorrhage. Ann Neurol 1991; 29: Kumar S, Goddeau RP, Selim MH, et al. Atraumatic convexal subarachnoid hemorrhage: clinical presentation, imaging patterns, and etiologies. Neurology 2010; 74: Kang D-H, Park J, Lee S-H, Park S-H, Kim Y-S, Hamm I-S. Does non-perimesencephalic type non-aneurysmal subarachnoid hemorrhage have a benign prognosis? J Clin Neurosci 2009; 16: Maslehaty H, Petridis AK, Barth H, Mehdorn HM. Diagnostic value of magnetic resonance imaging in perimesencephalic and nonperimesencephalic subarachnoid hemorrhage of unknown origin. J Neurosurg 2011; 114: Canh~ao P, Ferro JM, Pinto AN, Melo TP, Campos JG. Perimesencephalic and nonperimesencephalic subarachnoid haemorrhages with negative angiograms. Acta Neurochir (Wien) 1995; 132: Canovas D, Gil A, Jato M, de Miquel M, Rubio F. Clinical outcome of spontaneous non-aneurysmal subarachnoid hemorrhage in 108 patients. Eur J Neurol 2012; 19: Konczalla J, Platz J, Brawanski N, et al. Endovascular and surgical treatment of internal carotid bifurcation aneurysms: comparison of results, outcome, and midterm follow-up. Neurosurgery 2015; 76: Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: The Health Institute, New England Medical Center, Dillman DA. Mail and Internet Surveys: The Tailored Design Method 2007 Update with New Internet, Visual, and Mixed-Mode Guide, 2nd edn. Hoboken, NJ: John Wiley & Sons, Woznica M, Rosahl SK, Berlis A, Weyerbrock A. Outcome correlates with blood distribution in subarachnoid hemorrhage of unknown origin. Acta Neurochir (Wien) 2010; 152: Hop JW, Rinkel GJ, Algra A, van Gijn J. Quality of life in patients and partners after aneurysmal subarachnoid hemorrhage. Stroke 1998; 29: Kapapa T, Woischneck D, Tjahjadi M. Long-term health-related quality of life after spontaneous nontraumatic subarachnoid hemorrhage: self and proxy reports in a 10-year period. World Neurosurg 2014; 81: Tjahjadi M, Heinen C, K onig R, et al. Health-related quality of life after spontaneous subarachnoid hemorrhage measured in a recent patient population. World Neurosurg 2013; 79: Boswell S, Thorell W, Gogela S, Lyden E, Surdell D. Angiogram-negative subarachnoid hemorrhage: outcomes data and review of the literature. J Stroke Cerebrovasc Dis 2013; 22:
Isolated Cranial Nerve-III Palsy Secondary to Perimesencephalic Subarachnoid Hemorrhage
Lehigh Valley Health Network LVHN Scholarly Works Department of Medicine Isolated Cranial Nerve-III Palsy Secondary to Perimesencephalic Subarachnoid Hemorrhage Hussam A. Yacoub MD Lehigh Valley Health
More informationJournal of Clinical Neuroscience
Journal of Clinical Neuroscience 16 (2009) 904 908 Contents lists available at ScienceDirect Journal of Clinical Neuroscience journal homepage: www.elsevier.com/locate/jocn Clinical Study Does non-perimesencephalic
More informationEpidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital
ISPUB.COM The Internet Journal of Neurosurgery Volume 9 Number 2 Epidemiology And Treatment Of Cerebral Aneurysms At An Australian Tertiary Level Hospital A Granger, R Laherty Citation A Granger, R Laherty.
More informationTreatment of Acute Hydrocephalus After Subarachnoid Hemorrhage With Serial Lumbar Puncture
19 Treatment of Acute After Subarachnoid Hemorrhage With Serial Lumbar Puncture Djo Hasan, MD; Kenneth W. Lindsay, PhD, FRCS; and Marinus Vermeulen, MD Downloaded from http://ahajournals.org by on vember,
More informationFamilial perimesencephalic subarachnoid hemorrhage: two case reports
Cıkla et al. Journal of Medical Case Reports 2014, 8:380 JOURNAL OF MEDICAL CASE REPORTS CASE REPORT Open Access Familial perimesencephalic subarachnoid hemorrhage: two case reports Ulaş Cıkla 1, Beverly
More informationTime-Dependent Test Characteristics of Head Computed Tomography in Patients Suspected of Nontraumatic Subarachnoid Hemorrhage
Time-Dependent Test Characteristics of Head Computed Tomography in Patients Suspected of Nontraumatic Subarachnoid Hemorrhage Daan Backes, MSc; Gabriel J.E. Rinkel, MD; Hans Kemperman, PhD; Francisca H.H.
More informationGuideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management
0 0 NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Guideline scope Subarachnoid haemorrhage caused by a ruptured aneurysm: diagnosis and management The Department of Health and Social Care in England
More informationDiagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes
Diagnosis of Subarachnoid Hemorrhage (SAH) and Non- Aneurysmal Causes By Sheila Smith, MD Swedish Medical Center 1 Disclosures I have no disclosures 2 Course Objectives Review significance and differential
More informationPaul Gigante HMS IV Gillian Lieberman, MD. Sept Mr. T s T s Headache. Paul Gigante,, Harvard Medical School Year IV Gillian Lieberman, MD
Sept 2005 Mr. T s T s Headache Paul Gigante,, Harvard Medical School Year IV Mr. T s T s Presentation 45 year-old welder complains of sudden severe headache and witnessed seizure with loss of consciousness
More informationIn approximately 15% of patients with spontaneous
1507 Perimesencephalic Subarachnoid Hemorrhage Additional Perspectives From Four Cases Wouter I. Schievink, MD; Eelco F.M. Wijdicks, MD; David G. Piepgras, MD; Douglas A. Nichols, MD; Michael J. Ebersold,
More informationPerforator aneurysms of the posterior circulation. Spontaneous resolution of perforator aneurysms of the posterior circulation.
J Neurosurg 121:1107 1111, 2014 AANS, 2014 Spontaneous resolution of perforator aneurysms of the posterior circulation Report of 3 cases Adrien Chavent, M.D., 1 Pierre-Henri Lefevre, M.D., 1 Pierre Thouant,
More informationClinical trial registration no.: NCT (clinicaltrials.gov) https://thejns.org/doi/abs/ / jns161301
CLINICAL ARTICLE J Neurosurg 128:120 125, 2018 Analysis of saccular aneurysms in the Barrow Ruptured Aneurysm Trial Robert F. Spetzler, MD, 1 Joseph M. Zabramski, MD, 1 Cameron G. McDougall, MD, 1 Felipe
More informationShort-term Tranexamic Acid Treatment in Aneurysmal Subarachnoid Hemorrhage
4 Short-term Tranexamic Acid Treatment in Aneurysmal Subarachnoid Hemorrhage Eelco F.M. Wijdicks, MD, Djo Hasan, MD, Kenneth W. Lindsay, PhD, FRCS, Paul J.A.M. Brouwers, MD, Richard Hatfield, FRCS, Gordon
More informationThe presence of a severe, sudden headache, often referred
Sentinel Headache and the Risk of After Aneurysmal Subarachnoid Hemorrhage Jürgen Beck, MD; Andreas Raabe, MD, PhD; Andrea Szelenyi, MD; Joachim Berkefeld, MD, PhD; Rüdiger Gerlach, MD, PhD; Matthias Setzer,
More informationNonaneurysmal Perimesencephalic Subarachnoid Hemorrhage: CT and MR Patterns That Differ from Aneurysmal Rupture
829 Nonaneurysmal Perimesencephalic Subarachnoid Hemorrhage: CT and MR Patterns That Differ from Aneurysmal Rupture Gabriel J. E. Rinkel 1 Eelco F. M. Wijdicks 1 Marinus Vermeulen 2 Lino M. P. Ramos 3
More informationRESEARCH HUMAN CLINICAL STUDIES
TOPIC RESEARCH HUMAN CLINICAL STUDIES RESEARCH HUMAN CLINICAL STUDIES Richard Dalyai, MD Nohra Chalouhi, MD Thana Theofanis, BS Pascal M. Jabbour, MD Aaron S. Dumont, MD L. Fernando Gonzalez, MD David
More informationPerimesencephalic nonaneurysmal hemorrhage (PMH),
Venous Drainage in Perimesencephalic Hemorrhage Irene C. van der Schaaf, MD; Birgitta K. Velthuis, MD; Alida Gouw, MSc; Gabriel J.E. Rinkel, MD Background and Purpose In perimesencephalic nonaneurysmal
More informationAmong patients with a subarachnoid hemorrhage
Origin of Pretruncal Nonaneurysmal Subarachnoid Hemorrhage: Ruptured Vein, Perforating Artery, or Intramural Hematoma? WOUTER I. SCHIEVINK, MD, AND EELCO F. M. WUDICKS, MD Pretruqeal (perimesencephalic)
More informationAssessment of Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Current concepts and Value of CT Perfusion and CT Angiography
Assessment of Vasospasm and Delayed Cerebral Ischemia after Subarachnoid Hemorrhage: Current concepts and Value of CT Perfusion and CT Angiography Poster No.: C-2563 Congress: ECR 2012 Type: Educational
More informationCorrelation of revised fisher scale with clinical
Research Article Correlation of revised fisher scale with clinical grading (WFNS) in patients with non-traumatic subarachnoid haemorrhage Basti Ram S. 1, Kumbar Vishwanath G. 2*, Nayak Madhukar T., Xavier
More informationClinical manifestations, diagnosis and medical management of
Clinical manifestations, diagnosis and medical management of aneurysmal SAH David Bervini, MD MAdvSurg Department of Neurosurgery Inselspital University of Bern Switzerland 1 2 3 Aneurysmal SAH Incidence:
More informationReceived: 15 September 2014 /Accepted: 20 November 2014 /Published online: 6 December 2014 # Springer-Verlag Berlin Heidelberg 2014
Neuroradiology (2015) 57:269 274 DOI 10.1007/s00234-014-1472-6 DIAGNOSTIC NEURORADIOLOGY Quantification of structural cerebral abnormalities on MRI 18 months after aneurysmal subarachnoid hemorrhage in
More informationDepartment of Neurosurgery, Medical Research Institute, Pusan National University College of Medicine and Hospital, Busan, Korea
Journal of Cerebrovascular and Endovascular Neurosurgery pissn 2234-8565, eissn 2287-3139, http://dx.doi.org/10.7461/jcen.2015.17.1.20 Case Report Contrast Extravasation on Computed Tomography Angiography
More informationThe development of delayed cerebral ischemia (DCI)
clinical article J Neurosurg 6:50 50, 07 Increased risk of delayed cerebral ischemia in subarachnoid hemorrhage patients with additional intracerebral hematoma Johannes Platz, MD, Erdem Güresir, MD, PhD,
More informationExtent of subarachnoid hemorrhage and development of hydrocephalus
Clinical Science Extent of subarachnoid hemorrhage and development of hydrocephalus Mirsad Hodžić, Mirza Moranjkić, Zlatko Ercegović, Harun Brkić Department of neurosurgery, University Clinical Center
More informationClinical Review of 20 Cases of Terson s Syndrome
34 Clinical Review of 20 Cases of Terson s Syndrome Takashi SUGAWARA, M.D., Yoshio TAKASATO, M.D., Hiroyuki MASAOKA, M.D., Yoshihisa OHTA, M.D., Takanori HAYAKAWA, M.D., Hiroshi YATSUSHIGE, M.D., Shogo
More information(aneurysmal subarachnoid hemorrhage, 17%~60% :SAH. ,asah , 22%~49% : Willis. :1927 Moniz ;(3) 2. ischemic neurological deficit,dind) SAH) SAH ;(6)
,, 2. : ;,, :(1), (delayed ;(2) ischemic neurological deficit,dind) ;(3) 2. :SAH ;(4) 5-10 10 HT -1-1 ;(5), 10 SAH ;(6) - - 27%~50%, ( cerebral vasospasm ) Glasgow (Glasgow Coma Scale,GCS), [1],, (aneurysmal
More informationSciences, Sri Ramachandra Medical College and Research Institute, Chennai, India.
IMAGES in PAEDIATRIC CARDIOLOGY Devara K V A, 1 Joseph S, 2 Uppu S C. 3 Spontaneous Subarachnoid Haemorrhage Due to Coarctation of Aorta and 1 Department of Radiology, Medall Healthcare Private Ltd, King
More informationTHE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F.
THE EFFICACY AND SAFETY OF CILOSTAZOL IN SUBARACHNOID HEMORRHAGE. A META- ANALYSIS OF RANDOMIZED AND NON RANDOMIZED STUDIES DR. MUHAMMAD F. ISHFAQ ZEENAT QURESHI STROKE INSTITUTE AND UNIVERSITY OF TENNESSEE,
More informationSub-arachnoid haemorrhage
Sub-arachnoid haemorrhage Dr Mary Newton Consultant Anaesthetist The National Hospital for Neurology and Neurosurgery UCL Hospitals NHS Trust mary.newton@uclh.nhs.uk Kiev, Ukraine September 17 th 2009
More informationFactors Influencing Long-Term Health-Related Quality of Life Among Patients After Aneurysmal and Nonaneurysmal Subarachnoid Hemorrhage: A Dissertation
University of Massachusetts Medical School escholarship@umms Graduate School of Nursing Dissertations Graduate School of Nursing 11-14-2011 Factors Influencing Long-Term Health-Related Quality of Life
More informationClinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm. Gab Teug Kim, M.D.
/ 119 = Abstract = Clinical Analysis of Risk Factors Affecting Rebleeding in Patients with an Aneurysm Gab Teug Kim, M.D. Department of Emergency Medicine, College of Medicine, Dankook University, Choenan,
More informationBrain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage
Cronicon OPEN ACCESS EC PAEDIATRICS Case Report Brain AVM with Accompanying Venous Aneurysm with Intracerebral and Intraventricular Hemorrhage Dimitrios Panagopoulos* Neurosurgical Department, University
More informationImpact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage
Impact of a Protocol for Acute Antifibrinolytic Therapy on Aneurysm Rebleeding After Subarachnoid Hemorrhage Robert M. Starke, BA; Grace H. Kim, MD; Andres Fernandez, MD; Ricardo J. Komotar, MD; Zachary
More informationTrigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics
J Neurol (2012) 259:1298 1302 DOI 10.1007/s00415-011-6341-1 ORIGINAL COMMUNICATION Trigger factors for rupture of intracranial aneurysms in relation to patient and aneurysm characteristics Monique H. M.
More information<INSERT COUNTRY/SITE NAME> All Stroke Events
WHO STEPS STROKE INSTRUMENT For further guidance on All Stroke Events, see Section 5, page 5-15 All Stroke Events Patient Identification and Patient Characteristics (I 1) Stroke
More informationHIROYUKI HASHIMOTO, M.D., JUN-ICHI IIDA, M.D., YASUO HIRONAKA, M.D., MASATO OKADA, M.D., AND TOSHISUKE SAKAKI, M.D.
J Neurosurg 92:278 283, 2000 Use of spiral computerized tomography angiography in patients with subarachnoid hemorrhage in whom subtraction angiography did not reveal cerebral aneurysms HIROYUKI HASHIMOTO,
More informationN E W T O N. Hänggi D, Etminan N, Macdonald RL, Steiger HJ, Mayer SA, Aldrich F, Diringer MN, Hoh BJ, Mocco J, Strange P, Faleck HJ, Miller M
N E W T O N Nimodipine microparticles to Enhance recovery While reducing TOxicity after subarachnoid hemorrhage Phase 1/2a Multicenter, Controlled, Randomized, Open Label, Dose Escalation, Safety, Tolerability,
More informationIntra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage
Romanian Neurosurgery (2016) XXX 4: 461 466 461 DOI: 10.1515/romneu-2016-0074 Intra-arterial nimodipine for the treatment of vasospasm due to aneurysmal subarachnoid hemorrhage A. Chiriac, Georgiana Ion*,
More informationThe Yield of Head CT in Syncope: A Pilot Study
The Yield of Head CT in Syncope: A Pilot Study The Harvard community has made this article openly available. Please share how this access benefits you. Your story matters. Citation Published Version Accessed
More informationはじめに 対象と方法 39: , 2017 SAH 183 WFNS
39:107 原 著 39: 107 112, 2017 1 2 1 1 1 1 要旨 SAH 2010 1 2013 12 SAH 253 183 64 70 WFNS I III 72.7 Fisher CT 3 86.3 19.9 16.6 GR MD 73.2 73.1 80 WFNS Key words: subarachnoid hemorrhage, prognosis, rate of
More informationLong-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk
Long-Term Excess Mortality After Aneurysmal Subarachnoid Hemorrhage Patients With Multiple Aneurysms at Risk Justiina Huhtakangas, MD; Hanna Lehto, MD; Karri Seppä, MSc, PhD; Riku Kivisaari, MD, PhD; Mika
More informationMethod Hannah Shotton
#asah Method Hannah Shotton 2 Introduction SAH Rupturing aneurysm Poor outlook Intervention Secure the aneurysm: clipping or coiling Recommended 48 hours Regional Specialist NSC Conservative management
More informationA report of nontraumatic cortical subarachnoid hemorrhage and subsequent management
For reprint orders, please contact: reprints@futuremedicine.com A report of nontraumatic cortical subarachnoid hemorrhage and subsequent management David Qiyuan Mao*,1, Daniel Addess 1 & Helen Valsamis
More informationSubarachnoid hemorrhage and negative angiography: clinical course and long-term follow-up
DOI 10.1007/s10143-011-0323-8 ORIGINAL ARTICLE Subarachnoid hemorrhage and negative angiography: clinical course and long-term follow-up Marco Fontanella & Innocenzo Rainero & Pier Paolo Panciani & Bawarjan
More informationEffect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms
J Neurosurg 57:622-628, 1982 Effect of early operation for ruptured aneurysms on prevention of delayed ischemic symptoms MAMORU TANEDA, M.D. Department of Neurosurgery, Hanwa Memorial Hospital, Osaka,
More information뇌동맥류수술시기와방법에따른 Shunt 수술의빈도 : 뇌동맥류파열 514 예분석 *
KISEP Clinical Research J Korean Neurosurg Soc 28486-492, 1999 뇌동맥류수술시기와방법에따른 Shunt 수술의빈도 : 뇌동맥류파열 514 예분석 * 공민호 신용삼 허승곤 김동익 ** 이규창 = Abstract = Frequency of Shunt Surgery according to the Timing and Method
More informationIsolated perimesencephalic subarachnoid hemorrhage
Cost-Effectiveness of Angiographic Imaging in Isolated Perimesencephalic Subarachnoid Hemorrhage Vivek B. Kalra, MD; Xiao Wu, BS; Howard P. Forman, MD, MBA; Ajay Malhotra, MD Background and Purpose The
More informationRerupture of intracranial aneurysms: a clinicoanatomic study
J Neurosurg 67:29-33, 1987 Rerupture of intracranial aneurysms: a clinicoanatomic study ALBERT HIJDRA, M.D., MARINUS VERMEULEN, M.D., JAN VAN GIJN, M.D., AND HANS VAN CREVEL, M.D. Departments ~[ Neurology.
More informationNontraumatic subarachnoid hemorrhage
CLINICAL STUDIES Damien Biotti, MD Agnès Jacquin, MD Mahjouba Boutarbouch, MD Olivier Bousquet, MD Jérôme Durier, PhD Douraïeb Ben Salem, MD Department of Neuroimaging, Frederic Ricolfi, MD Department
More informationIschemic Stroke in Critically Ill Patients with Malignancy
Ischemic Stroke in Critically Ill Patients with Malignancy Jeong-Am Ryu 1, Oh Young Bang 2, Daesang Lee 1, Jinkyeong Park 1, Jeong Hoon Yang 1, Gee Young Suh 1, Joongbum Cho 1, Chi Ryang Chung 1, Chi-Min
More informationPerimesencephalic subarachnoid hemorrhage with a positive angiographic finding
https://helda.helsinki.fi Perimesencephalic subarachnoid hemorrhage with a positive angiographic finding Hafez, Ahmad 2016-06 Hafez, A, Numminen, J, Raj, R, Järveläinen, J & Niemela, M 2016, ' Perimesencephalic
More informationBecause of its occurrence at young age and its often poor
Magnesium Sulfate in Aneurysmal Subarachnoid Hemorrhage A Randomized Controlled Trial Walter M. van den Bergh; on behalf of the MASH Study Group Background and Purpose Magnesium reverses cerebral vasospasm
More informationPredictors of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Cardiac Focus
Neurocrit Care (2010) 13:366 372 DOI 10.1007/s12028-010-9408-4 ORIGINAL ARTICLE Predictors of Delayed Cerebral Ischemia After Aneurysmal Subarachnoid Hemorrhage: A Cardiac Focus Khalil Yousef Elizabeth
More informationMoyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature
Romanian Neurosurgery Volume XXXI Number 3 2017 July-September Article Moyamoya Syndrome with contra lateral DACA aneurysm: First Case report with review of literature Ashish Kumar Dwivedi, Pradeep Kumar,
More informationAzygos anterior cerebral artery aneurysm with subarachnoid hemorrhage
Chowdhury et al. Neuroimmunol Neuroinflammation 2018;5:39 DOI: 10.20517/2347-8659.2018.37 Neuroimmunology and Neuroinflammation Letter to Editor Open ccess zygos anterior cerebral artery aneurysm with
More informationINTRODUCTION. O riginal A rticle. Singapore Med J 2013; 54(6): doi: /smedj
Singapore Med J 2013; 54(6): 332-338 doi: 10.11622/smedj.2013127 Management of ruptured intracranial aneurysms in the post-isat era: outcome of surgical clipping versus endovascular coiling in a Singapore
More informationOriginal Article. Emergency Department Evaluation of Ventricular Shunt Malfunction. Is the Shunt Series Really Necessary? Raymond Pitetti, MD, MPH
Original Article Emergency Department Evaluation of Ventricular Shunt Malfunction Is the Shunt Series Really Necessary? Raymond Pitetti, MD, MPH Objective: The malfunction of a ventricular shunt is one
More informationAdmission criteria to the Danish Brain Cancer Program are moderately associated with magnetic resonance imaging findings
Dan Med J 60/3 March 2013 danish medical JOURNAL 1 Admission criteria to the Danish Brain Cancer Program are moderately associated with magnetic resonance imaging findings Thomas Winther Hill, Mie Kiszka
More informationExpert Opinion. Sentinel Headache CLINICAL HISTORY. Randolph W. Evans, MD; Esma Dilli, MD; David W. Dodick MD
Headache 2009 the Authors Journal compilation 2009 American Headache Society ISSN 0017-8748 doi: 10.1111/j.1526-4610.2009.01381.x Published by Wiley Periodicals, Inc. Expert Opinion (Headache 2009;49:599-603)
More informationClinic of Geriatrics, Faculty of Health Sciences, Collegium Medicum, Nicolaus Copernicus University, Toruń, Poland 3
Original papers Application of the functional capacity scale in the early assessment of functional efficiency in patients after aneurysm embolization: Preliminary reports Robert Ślusarz 1, A D, F, Monika
More informationSubarachnoid Haemorrhage and Sports
Received: May 17, 2015 Accepted: September 29, 2015 Published online: November 4, 2015 2015 The Author(s) Published by S. Karger AG, Basel 1664 5456/15/0053 0146$39.50/0 This article is licensed under
More informationEffect of clot removal on cerebral vasospasm TETSUJI INAGAWA, M.D., MITSUO YAMAMOTO, M.D., AND KAZUKO KAMIYA, M.D.
J Neurosurg 72:224-230, 1990 Effect of clot removal on cerebral vasospasm TETSUJI INAGAWA, M.D., MITSUO YAMAMOTO, M.D., AND KAZUKO KAMIYA, M.D. Department of Neurosurgery, Shimane Prefectural Central Hospital,
More informationLong-term MRA follow-up after coiling of intracranial aneurysms: impact on mood and anxiety
Neuroradiology (2011) 53:343 348 DOI 10.1007/s00234-010-0726-1 INTERVENTIONAL NEURORADIOLOGY Long-term MRA follow-up after coiling of intracranial aneurysms: impact on mood and anxiety Sandra P. Ferns
More informationA Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation
A Less Invasive Approach for Ruptured Aneurysm with Intracranial Hematoma: Coil Embolization Followed by Clot Evacuation Je Hoon Jeong, MD 1 Jun Seok Koh, MD 1 Eui Jong Kim, MD 2 Index terms: Endovascular
More informationProgress Review. Mervyn D.I. Vergouwen, MD, PhD; Rob J. de Haan, PhD; Marinus Vermeulen, MD, PhD; Yvo B.W.E.M. Roos, MD, PhD
Progress Review Effect of Statin Treatment on Vasospasm, Delayed Cerebral Ischemia, and Functional Outcome in Patients With Aneurysmal Subarachnoid Hemorrhage A Systematic Review and Meta-Analysis Update
More informationDelayed cerebral ischemia (DCI) is an important cause for
Prognostic Value of Cerebral Perfusion Computed Tomography in the Acute Stage After Subarachnoid Hemorrhage for the Development of Delayed Cerebral Ischemia Irene van der Schaaf, MD; Marieke J. Wermer,
More informationSurgery for angiographically occult cerebral aneurysms. Department of Neurosurgery, New York University Medical Center, New York, New York
J Neurosurg 79:674-679, 1993 Surgery for angiographically occult cerebral aneurysms JAFAR J. JAFAR, M.D., AND HOWARD L. WEINER, M.D. Department of Neurosurgery, New York University Medical Center, New
More informationCerebral aneurysms A case study
August 2001 Cerebral aneurysms A case study Heather L. Hinds, Harvard Medical School Year III Our Patient 57yr old woman History of migraines Presents with persistent headache several months duration different
More informationComparison of Incidence and Risk Factors for Shunt-dependent Hydrocephalus in Aneurysmal Subarachnoid Hemorrhage Patients
Journal of Cerebrovascular and Endovascular Neurosurgery ISSN 2234-8565, EISSN 2287-3139, http://dx.doi.org/10.7461/jcen.2014.16.2.78 Original Article Comparison of Incidence and Risk Factors for Shunt-dependent
More informationRuptured Cerebral Aneurysm of the Anterior Circulation
Original Articles * Division of Neurosurgery Department of Surgery Ruptured Cerebral Aneurysm of the Anterior Circulation Management and Microsurgical Treatment Ossama Al-Mefty, MD* ABSTRACT Based on the
More informationThunderclap. Making Evidence Matter
Thunderclap Making Evidence Matter Disclosures Paid Editorial Role JAMA s The Rational Clinical Examination No other disclosures or conflicts of interest Objectives Recognize the evidence cycle and hierarchy
More informationSubarachnoid Haemorrhage
Subarachnoid Haemorrhage a study on long-term consequences Wendy Boerboom Subarachnoid Haemorrhage a study on long-term consequences Wendy Boerboom The research described in this thesis was supported by
More informationIntracranial aneurysms are being treated with increasing frequency. Treatment of Poor-Grade Subarachnoid Hemorrhage Trial
Published July 24, 2014 as 10.3174/ajnr.A4061 ORIGINAL RESEARCH INTERVENTIONAL Treatment of Poor-Grade Subarachnoid Hemorrhage Trial D. Mitra, B. Gregson, V. Jayakrishnan, A. Gholkar, A. Vincent, P. White,
More informationDistinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage
ORIGINAL ARTICLE Distinguishing clinical and radiological features of non-traumatic convexal subarachnoid hemorrhage J. Graff-Radford, J. E. Fugate, J. Klaas, K. D. Flemming, R. D. Brown and A. A. Rabinstein
More informationDistal anterior cerebral artery (DACA) aneurysms are. Case Report
248 Formos J Surg 2010;43:248-252 Distal Anterior Cerebral Artery Aneurysm: an Infrequent Cause of Transient Ischemic Attack Followed by Diffuse Subarachnoid Hemorrhage: Report of a Case Che-Chuan Wang
More informationSupratentorial cerebral arteriovenous malformations : a clinical analysis
Original article: Supratentorial cerebral arteriovenous malformations : a clinical analysis Dr. Rajneesh Gour 1, Dr. S. N. Ghosh 2, Dr. Sumit Deb 3 1Dept.Of Surgery,Chirayu Medical College & Research Centre,
More informationGuidelines for the management of a patient with a subarachnoid haemorrhage
Guidelines for the management of a patient with a subarachnoid haemorrhage Item Type Report Authors Health Service Executive (HSE) Citation Health Service Executive. Guidelines for the management of a
More informationAneurysm Treatment <24 Versus h After Subarachnoid Hemorrhage
Neurocrit Care (2014) 21:4 13 DOI 10.1007/s12028-014-9969-8 ORIGINAL ARTICLE Aneurysm Treatment
More informationThe "filling defect" sign helps localise the site of intracranial aneurysm rupture on an unenhanced CT
The "filling defect" sign helps localise the site of intracranial aneurysm rupture on an unenhanced CT Poster No.: C-3380 Congress: ECR 2010 Type: Topic: Authors: Keywords: DOI: Educational Exhibit Neuro
More informationChapter Five. Anosmia after aneurysmal subarachnoid hemorrhage. M.J.H. Wermer, M. Donswijk, P. Greebe, B. Verweij and G.J.E.
Chapter Anosmia after aneurysmal subarachnoid hemorrhage M.J.H. Wermer, M. Donswijk, P. Greebe, B. Verweij and G.J.E. Rinkel Abstract Background and purpose Anosmia has an important impact on well-being,
More informationDiagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients
AJNR Am J Neuroradiol 0:7, January 999 Diagnostic and Therapeutic Consequences of Repeat Brain Imaging and Follow-up Vascular Imaging in Stroke Patients Birgit Ertl-Wagner, Tobias Brandt, Christina Seifart,
More informationAndrew J Molyneux, Richard S C Kerr, Jacqueline Birks, Najib Ramzi, Julia Yarnold, Mary Sneade, Joan Rischmiller, for the ISAT collaborators
Risk of recurrent subarachnoid haemorrhage, death, or dependence and standardised mortality ratios after clipping or coiling of an intracranial aneurysm in the International Subarachnoid Aneurysm Trial
More informationRisk Factors Associated with Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage
ORIGINAL ARTICLE Neurol Med Chir (Tokyo) 54, 465 473, 2014 doi: 10.2176/nmc.oa.2013-0169 Online March 27, 2014 Risk Factors Associated with Cerebral Vasospasm following Aneurysmal Subarachnoid Hemorrhage
More informationBleeding in the brain: haemorrhagic stroke
Call the Stroke Helpline: 0303 3033 100 or email: info@stroke.org.uk Bleeding in the brain: haemorrhagic stroke Some strokes are due to bleeding in or around the brain, and are known as haemorrhagic strokes.
More informationSAH READMISSIONS TO NCCU
SAH READMISSIONS TO NCCU Are they preventable? João Amaral Rebecca Gorf Critical Care Outreach Team - NHNN 2015 Total admissions to NCCU =862 Total SAH admitted to NCCU= 104 (93e) (12.0%) Total SAH readmissions=
More informationCT angiography and its role in the investigation of intracranial haemorrhage
CT angiography and its role in the investigation of intracranial haemorrhage RD Magazine, 39, 458, 29-30 Dr M Igra Radiology SPR Leeds General Infirmary Dr I Djoukhadar Research fellow Wolfson Molecular
More informationEndovascular Treatment for Acute Ischemic Stroke
ular Treatment for Acute Ischemic Stroke Vishal B. Jani MD Assistant Professor Interventional Neurology, Division of Department of Neurology. Creighton University/ CHI health Omaha NE Disclosure None 1
More informationQuantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage
Quantitative Analysis of Hemorrhage Volume for Predicting Delayed Cerebral Ischemia After Subarachnoid Hemorrhage Sang-Bae Ko, MD, PhD; H. Alex Choi, MD; Amanda Mary Carpenter, BA; Raimund Helbok, MD;
More informationSpontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke
Original Contribution Spontaneous Recanalization after Complete Occlusion of the Common Carotid Artery with Subsequent Embolic Ischemic Stroke Abstract Introduction: Acute carotid artery occlusion carries
More informationUltra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial
Germans et al. Trials 2013, 14:143 TRIALS STUDY PROTOCOL Open Access Ultra-early tranexamic acid after subarachnoid hemorrhage (ULTRA): study protocol for a randomized controlled trial Menno R Germans
More informationDefinition พ.ญ.ส ธ ดา เย นจ นทร. Epidemiology. Definition 5/25/2016. Seizures after stroke Can we predict? Poststroke seizure
Seizures after stroke Can we predict? พ.ญ.ส ธ ดา เย นจ นทร PMK Epilepsy Annual Meeting 2016 Definition Poststroke seizure : single or multiple convulsive episode(s) after stroke and thought to be related
More informationTHE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS
THE LONG TERM PSYCHOLOGICAL EFFECTS OF DAILY SEDATIVE INTERRUPTION IN CRITICALLY ILL PATIENTS John P. Kress, MD, Brian Gehlbach, MD, Maureen Lacy, PhD, Neil Pliskin, PhD, Anne S. Pohlman, RN, MSN, and
More informationSubarachnoid Hemorrhage and Brain Aneurysm
Subarachnoid Hemorrhage and Brain Aneurysm DIN Department of Interventional Neurology What is SAH? Subarachnoid Haemorrhage is the sudden leaking (haemorrhage) of blood from the blood vessels of brain.
More informationSubarachnoid Hemorrhage (SAH) Disclosures/Relationships. Click to edit Master title style. Click to edit Master title style.
Subarachnoid Hemorrhage (SAH) William J. Jones, M.D. Assistant Professor of Neurology Co-Director, UCH Stroke Program Click to edit Master title style Disclosures/Relationships No conflicts of interest
More informationImpact of traumatic subarachnoid hemorrhage on outcome in nonpenetrating head injury
J Neurosurg 83:445 452, 1995 Impact of traumatic subarachnoid hemorrhage on outcome in nonpenetrating head injury Part I: A proposed computerized tomography grading scale KARL A. GREENE, M.D., PH.D., FREDERICK
More information